Cargando…
Development of Biodegradable Nanocarriers Loaded with a Monoclonal Antibody
Treatments utilizing monoclonal antibody therapeutics against intracellular protein-protein interactions in cancer cells have been hampered by several factors, including poor intracellular uptake and rapid lysosomal degradation. Our current work examines the feasibility of encapsulating monoclonal a...
Autores principales: | Gdowski, Andrew, Ranjan, Amalendu, Mukerjee, Anindita, Vishwanatha, Jamboor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346939/ https://www.ncbi.nlm.nih.gov/pubmed/25690029 http://dx.doi.org/10.3390/ijms16023990 |
Ejemplares similares
-
Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy
por: Ranjan, Amalendu P, et al.
Publicado: (2012) -
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
por: Gdowski, Andrew S., et al.
Publicado: (2017) -
Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation
por: Ranjan, Amalendu P, et al.
Publicado: (2013) -
Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
por: Gdowski, Andrew S, et al.
Publicado: (2017) -
Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials
por: Gdowski, Andrew, et al.
Publicado: (2018)